Also trades as: 0J4V.L (LSE) · $vol 0M
HRTX NASDAQ
Heron Therapeutics, Inc.
1W: -4.5%
1M: -14.6%
3M: -26.2%
YTD: -30.9%
1Y: -54.6%
3Y: -30.9%
5Y: -93.7%
$0.86
-0.01 (-1.42%)
Weekly Expected Move ±16.6%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$151M
Revenue
+1.5% YoY
$-31M
Net Income
-297.4% YoY
$-21M
Free Cash Flow
+12.0% YoY
69.4%
Gross Margin
-13.7%
Op. Margin
-23.4%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE320.3%
ROA-12.7%
ROIC-7.6%
Valuation
P/E-5.3
P/B17.8
EV/EBITDA-12.0
Leverage
Debt/Equity9.81
Current Ratio2.48
Interest Cov.-5.9x
Quality Scores
Piotroski F3/9
Altman Z-9.28
Beneish M-2.55